An Integrated Oncology Pipeline
Diagnostics + Therapeutics, powered by continuous discovery.
Strandwise is building a vertically integrated oncology pipeline that connects early detection, disease monitoring, and mechanism-driven therapeutic discovery into a single system.
Our pipeline is guided by Aetherion™, our autonomous scientific intelligence that continuously monitors biomedical research, prioritizes actionable hypotheses, and informs both our diagnostic and therapeutic programs.
PiPeline
Diagnostics Pipeline
Detection of free cancer cells and tumor-associated biological signatures.
Skopeion™ Biosensor Chip
Skopeion is our proprietary biosensor platform built with advanced nanotechnology to enable sensitive detection and monitoring workflows for oncology.
Therapeutics Pipeline
We currently have two molecular programs in the pipeline for gastrointestinal oncology.
Gastrointestinal Oncology: First Indications
We are initially focused on high-impact gastrointestinal cancers where earlier detection and better therapeutics can meaningfully change outcomes:
- Pancreatic cancer
- Colorectal cancer
- Gastric cancer
Two Therapeutic Candidates in Development
We currently have two molecular programs in the pipeline for gastrointestinal oncology.
Add a footnote if this applies to your business
Our Partners
Copyright © 2025 Strandwise - All Rights Reserved.
Powered by Aetherion
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.